Komrokji R, al Ali N, Chan O, Sweet K, Kuykendall A, Lancet J, Padron E, Sallman DA. IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy. Haematologica 2023;108(4):1168-1172; https://doi.org/10.3324/haematol.2022.281607.